Early symptoms of primary (AL) amyloidosis are non‐specific. Any delay in diagnosis and treatment results in poor outcome despite increasing treatment options. We aimed to determine baseline risk factors that… Click to show full abstract
Early symptoms of primary (AL) amyloidosis are non‐specific. Any delay in diagnosis and treatment results in poor outcome despite increasing treatment options. We aimed to determine baseline risk factors that identify patients with poor kidney outcomes and overall survivals.
               
Click one of the above tabs to view related content.